QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 baird-maintains-outperform-on-cencora-raises-price-target-to-395

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $355 to $395.

 mizuho-maintains-outperform-on-cencora-raises-price-target-to-380

Mizuho analyst Steven Valiquette maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $340 to $380.

 stocks-rebound-eli-lilly-jumps-to-14-month-highs-whats-moving-markets-wednesday

Wall Street bounced back Wednesday after Tuesday's sharp selloff in AI-driven stocks, as investors bought the dip amid soli...

 cencora-board-approves-9-increase-in-quarterly-dividend-to-060-per-share-payable-december-1-2025

Dividend DeclarationOn November 4, 2025, the Company's Board of Directors declared a quarterly dividend of $0.60 per common...

 cencora-sees-fy2026-adj-eps-1745-1775-vs-1594-est-sees-sales-337365b-343791b-vs-321030b-est

Fiscal Year 2026 Expectations on an Adjusted (non-GAAP) Basis 2026 GuidanceFiscal 2025 ActualsRevenue5% to 7% growth$321.3BU.S....

 cencora-q4-adj-eps-384-beats-379-estimate-sales-83700b-beat-83458b-estimate

Cencora (NYSE:COR) reported quarterly earnings of $3.84 per share which beat the analyst consensus estimate of $3.79 by 1.43 pe...

 mizuho-maintains-outperform-on-cencora-raises-price-target-to-340

Mizuho analyst Steven Valiquette maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $334 to $340.

 ubs-maintains-buy-on-cencora-raises-price-target-to-380

UBS analyst Kevin Caliendo maintains Cencora (NYSE:COR) with a Buy and raises the price target from $350 to $380.

 mizuho-maintains-outperform-on-cencora-raises-price-target-to-334

Mizuho analyst Steven Valiquette maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $316 to $334.

 cencoras-intrinsiq-expands-oncology-biomarker-data-and-therapeutic-insights-to-advance-precision-medicine-and-support-biopharmaceutical-innovation

Biomarker data, enhanced therapeutic data and insights will enable biopharmaceutical innovation and physician support through i...

Core News & Articles

https://www.youtube.com/watch?v=2KW1mVChh-c&feature=youtu.be

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION